RCM
MSACU

Radcliffe Capital Management’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Radcliffe Capital Management’s Portfolio MSACU Stock Details MSACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,883
Closed -$117K – 1110
2021
Q1 		$117K Buy
+11,883
New +$121K ﹤0.01% 683

Other funds holding MSACU

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Radcliffe Capital Management's MSACU Position: Q2 2021 in Review

Radcliffe Capital Management sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 11,883 shares — an estimated $117K sold.

Radcliffe Capital Management first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $117K in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

  • Radcliffe Capital Management reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • Radcliffe Capital Management sold 11,883 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $117K.
  • Radcliffe Capital Management first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • Radcliffe Capital Management's Medicus Sciences Acquisition Corp. Unit position peaked at $117K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on Radcliffe Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.